Tag: HIV medication

British drugs group GlaxoSmithKline is planning to create a new £15bn FTSE 100 company by spinning out a subsidiary focused on treating HIV.  Viiv Healthcare is expected to attract a "significant" capitalisation due to its rapid growth according to chief executive Sir Andrew Witty. ViiV's newest HIV medicines, Trumeq and Tivicay, have...